Previous 10 | Next 10 |
home / stock / lxxgf / lxxgf news
Phoenix, Arizona--(Newsfile Corp. - November 18, 2019) - The Stock Day Podcast welcomed LexaGene Holdings Inc. (OTCQB: LXXGF) ("the Company"), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers for on-site rapid testing in veterinary diag...
BEVERLY, Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, provides a corporate update. ...
BEVERLY, Mass., Oct. 29, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (TSX VENTURE: LXG) (OTCQB: LXXGF) (" LexaGene " or the " Company ") is pleased to announce that it has closed its previously announced offering of units (the “ Units ”) for aggregate gros...
LexaGene Holdings Announces Filing of Final Prospectus Canada NewsWire BEVERLY, MA, Oct. 22, 2019 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / BEVERLY, MA , Oct. 22, 2019 /CNW/ - LexaGene Holdings Inc. ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (TSX VENTURE: LXG ) (OTCQB: LXXGF ) ("LexaGene" or the " Company ") is pleased to announce today ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (TSX VENTURE: LXG) (OTCQB: LXXGF) ("LexaGene" or the "Company") is pleased to announce that it has...
BEVERLY, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today it has comple...
LexaGene (TSXV: LXG , OTCQB:LXXGF), a biotechnology based in Massachusetts, is focusing its efforts on tackling rapid pathogen detection by way of its genetic analyzer. A pathogen is a bacteria or infection that leads to disease. As described by the US National Institute of Medicine , p...
BEVERLY, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers that can rapidly detect pathogens and other molecular markers, announced today the development of a...
BEVERLY, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene”) or the (“Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers,...
News, Short Squeeze, Breakout and More Instantly...
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...
BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...
BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...